04.04.2016 • NewsBayerGELanxess

Gnann succeeds Hartel to Lead Wacker Silicones

Dr. Robert Gnann (51) has taken over as president of Wacker Chemie AG’s...
Dr. Robert Gnann (51) has taken over as president of Wacker Chemie AG’s WACKER SILICONES division effective April 1, 2016. (Photo: Wacker Chemie AG)

Dr. Robert Gnann (51) has taken over as president of Wacker Silicones effective April 1, 2016. He succeeds Dr. Christian Hartel, who was appointed to the Wacker Group’s Executive Board in early November 2015. Gnann comes to Wacker from Momentive Performance Materials, where he headed the chemical company’s elastomer and European activities.

After studying chemistry at the University of Cologne, Germany, and earning his doctorate, Robert Gnann began his career at GE Silicones in the USA in 1996. He then moved on to Bayer and Lanxess in Canada and Germany, where he held managerial positions in such areas as production and technology. From 2008, Gnann was responsible for the elastomers business unit at Momentive Performance Materials and, in 2010, additionally took charge of the company’s European activities.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.